| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 82.757 | 1.751.895 | 6.695.808 | 4.821.499 | 3.168.245 |
| Total Income - EUR | - | - | - | - | - | 82.761 | 1.752.059 | 6.695.925 | 4.821.708 | 3.181.500 |
| Total Expenses - EUR | - | - | - | - | - | 68.357 | 1.424.853 | 4.032.952 | 2.838.883 | 2.686.371 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 14.404 | 327.206 | 2.662.974 | 1.982.824 | 495.129 |
| Net Profit/Loss - EUR | - | - | - | - | - | 13.689 | 273.921 | 2.310.662 | 1.724.182 | 420.998 |
| Employees | - | - | - | - | - | 3 | 5 | 6 | 9 | 13 |
Check the financial reports for the company - Axioma Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 3.525 | 169.387 | 257.388 | 391.269 |
| Current Assets | - | - | - | - | - | 94.112 | 1.816.454 | 5.310.857 | 1.533.742 | 2.342.261 |
| Inventories | - | - | - | - | - | 0 | 9.873 | 393.774 | 132.329 | 697.469 |
| Receivables | - | - | - | - | - | 66.209 | 1.718.698 | 3.274.917 | 137.229 | 851.385 |
| Cash | - | - | - | - | - | 27.904 | 87.883 | 1.642.166 | 1.264.184 | 793.407 |
| Shareholders Funds | - | - | - | - | - | 13.730 | 279.581 | 2.317.808 | 1.742.584 | 431.098 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 80.709 | 1.540.538 | 3.165.732 | 70.942 | 2.302.815 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Axioma Medical S.r.l.